Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Disa Yu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|January 7, 2020
MatchMixeR: a cross-platform normalization method for gene expression data integrationSerin Zhang, Jiang Shao, Disa Yu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
PXN Unlocks the Power of Public Gene Expression Data Through Cross-Technology IntegrationZhining Sui, Disa Yu, Arslan Erdengasileng, et al.
Database : the Journal of Biological Databases and Curation|January 10, 2019
Extracting chemical-protein interactions from literature using sentence structure analysis and feature engineeringPei-Yau Lung, Zhe He, Tingting Zhao, et al.
Applied Geography (Sevenoaks, England)|October 12, 2020
Identifying county-level factors for female breast cancer incidence rate through a large-scale population studyTingting Zhao, Zihan Cui, Mary Grace McClellan, et al.
Future Oncology (London, England)|July 17, 2025
Plain language summary on subcutaneous administration of isatuximab in people with relapsed and/or refractory multiple myelomaHang Quach, Gurdeep Parmar, Enrique M Ocio, et al.
Haematologica|August 19, 2024
A multicenter, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myelomaHang Quach, Gurdeep Parmar, Enrique M Ocio, et al.
Blood Cancer Journal|December 27, 2025
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCOGurdeep Parmar, Marcelo Capra, Fernanda Seguro, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|January 7, 2020
MatchMixeR: a cross-platform normalization method for gene expression data integrationSerin Zhang, Jiang Shao, Disa Yu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
PXN Unlocks the Power of Public Gene Expression Data Through Cross-Technology IntegrationZhining Sui, Disa Yu, Arslan Erdengasileng, et al.
Database : the Journal of Biological Databases and Curation|January 10, 2019
Extracting chemical-protein interactions from literature using sentence structure analysis and feature engineeringPei-Yau Lung, Zhe He, Tingting Zhao, et al.
Applied Geography (Sevenoaks, England)|October 12, 2020
Identifying county-level factors for female breast cancer incidence rate through a large-scale population studyTingting Zhao, Zihan Cui, Mary Grace McClellan, et al.
Future Oncology (London, England)|July 17, 2025
Plain language summary on subcutaneous administration of isatuximab in people with relapsed and/or refractory multiple myelomaHang Quach, Gurdeep Parmar, Enrique M Ocio, et al.
Haematologica|August 19, 2024
A multicenter, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myelomaHang Quach, Gurdeep Parmar, Enrique M Ocio, et al.
Blood Cancer Journal|December 27, 2025
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCOGurdeep Parmar, Marcelo Capra, Fernanda Seguro, et al.
Pageof 1